Cite
HARVARD Citation
Hämetoja, H. et al. (2021). Antizyme inhibitor 2 (AZIN2) associates with better prognosis of head and neck minor salivary gland adenoid cystic carcinoma. Apmis. 129 (8), pp. 503-511. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hämetoja, H. et al. (2021). Antizyme inhibitor 2 (AZIN2) associates with better prognosis of head and neck minor salivary gland adenoid cystic carcinoma. Apmis. 129 (8), pp. 503-511. [Online].